What we do
We detect diseases at an earlier stage
Volv Global’s inTrigue machine learning technology detects incidence of disease earlier than currently possible, by analysing vast amounts of medical data to detecting subtle patterns among biomarkers.
This ensures that people on the path to developing diseases can have start their healthcare journey early by receiving early interventions. This improves patient outcomes, reduces healthcare burdens and improves quality of life.
